Sulfur mustard and respiratory diseases

Area of Science:

• Toxicology
• Pulmonary Medicine
• Chemical Warfare Agents

Background:

• Sulfur mustard (HD) exposure, from warfare or accidents, leads to acute respiratory discomfort and chronic lung diseases like fibrosis, bronchiolitis obliterans, and cancer.
• Molecular alterations, including changes in cytokines, chemokines, selectins, and Fas ligand, are linked to the development of HD-induced pulmonary pathologies.
• Previous research in animal models suggests specific molecular pathways and compounds as potential therapeutic targets.

Purpose of the Study:

• To systematically review the clinical and pathophysiological effects of sulfur mustard (HD) exposure on the respiratory system.
• To update clinicians and researchers on the mechanisms underlying acute and chronic lung damage induced by HD.
• To identify and discuss potential drug targets for developing antidotes against HD toxicity.

Main Methods:

• Systematic review of clinical data and pathophysiological changes in HD-exposed individuals.
• Analysis of molecular mechanisms, including cytokine/chemokine profiles and signaling pathways.
• Evaluation of experimental findings from rodent studies on protective agents and drug targets.

Main Results:

• Documented long-term respiratory and systemic health consequences of sulfur mustard (HD) exposure.
• Identified key molecular players (e.g., cytokines, sE-selectin, peroxynitrite) involved in HD-induced lung injury.
• Highlighted promising therapeutic targets (e.g., NOS, PARP, AP-1) and protective agents (e.g., N-acetyl cysteine, melatonin) from preclinical studies.

Conclusions:

• Sulfur mustard (HD) causes significant and lasting damage to the respiratory system through complex molecular mechanisms.
• Understanding these mechanisms is crucial for developing effective treatments and antidotes.
• Further research into identified drug targets and protective agents is warranted for clinical application.